Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 85.10
-7.70 (-8.30%)
Oct 22, 2026, 2:05 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 80.09 billion as of October 21, 2026. It is the 2,084th most valuable company in the world and the 111th biggest in Hong Kong. Its market cap has decreased by 27.24% in one year.
Market Cap
80.09B
Enterprise Value
75.12B
Revenue
3.98B
Global Rank
Country Rank
#111 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 80.09B, an increase of 331.90%. That is a compound annual growth rate of 25.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 80.09B | -23.06% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 205.39B |
| Innovent Biologics | 152.16B |
| Sichuan Kelun-Biotech Biopharmaceutical | 111.86B |
| Sino Biopharmaceutical | 96.17B |
| Genscript Biotech | 76.21B |
| RemeGen | 54.01B |
| Biocytogen Pharmaceuticals (Beijing) | 37.86B |
| 3SBio | 36.64B |